Alumni & Development
Milton Taylor Fellowship
Thanks to donors like you, the Taylor Fellowship currently generates an income of roughly $8,200 annually. With your support, this fellowship will continue to recognize a promising student, support virology research, and honor Milton Taylor.
Chenglei Li, 2013 Taylor Fellow
![]() Chenglei Li continues research begun by Milton Taylor in the 1970s. Courtesy photo |
Chenglei is a member of Adam Zlotnick’s lab. He is earning his Ph.D. in Biochemistry. Chenglei’s research involves the study of dodecahedral virus assembly using experimental and modeling approaches. His research is a continuation of a project that Milton Taylor did in the 1970s. Chenglei has three publications to his credit: one appeared in the Journal of Virology and the other two can be found in the Journal of the American Chemical Society. He has been an associate instructor for E105 Human Heredity; L313 Virology and Tissue Culture Lab; L112 Biological Mechanisms; and two semesters of L113 Biology Laboratory.
Anthony J. Snyder, 2013 Taylor Fellow
A. J. is earning his Ph.D. in Biochemistry. A member of Tuli Mukhopadhyay’s laboratory, A. J.’s research involves structure-function studies of the alphavirus E3 glycoprotein. He has had two papers published in the Journal of Virology and a third one was published in the journal Cancer. He taught L113 Biology Laboratory twice and in 2012 he received the Konetzka Fellowship that recognizes students with top-notch research and teaching skills.
About the Milton Taylor Fellowship
The Taylor Fellowship aids recruitment and retention of outstanding graduate students and can provide dissertation support. Graduate students conducting research in virology receive first preference. Undergraduate microbiology majors, who preferably are performing research in virology, may also apply for scholarships from this fund and receive second preference.
The endowed fellowship was created in 2000 by alumnus Lawrence Blatt to honor his former teacher and mentor, Professor Milton W. Taylor. In addition to studying under Taylor as an undergraduate, Blatt, now the President, CEO, and Chairman of the Board of Alios BioPharma, also began collaborating with Taylor on scientific projects in the early 1990s. They began researching the synergistic effects of interferon on virus replication and the study of gene expression using microarray technology.

